The exclusion criteria for pediatric patients aged <3 years included a clinical diagnosis of infantile-onset ASMD (NPD A) with evidence of developmental delay, or homozygosity for specific SMPD1 gene mutations (R496l, L302P, P330fs*52 or any combination of these mutations). The gene discussed is SMPD1; the disease is anterior segment dysgenesis.